Label: LABETALOL HCL injection, solution
-
Contains inactivated NDC Code(s)
NDC Code(s): 52533-034-20 - Packager: Cantrell Drug Company
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated May 2, 2014
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Label
- SPL UNCLASSIFIED SECTION
-
INGREDIENTS AND APPEARANCE
LABETALOL HCL
labetalol hcl injection, solutionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:52533-034 Route of Administration INTRAVENOUS Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LABETALOL HYDROCHLORIDE (UNII: 1GEV3BAW9J) (LABETALOL - UNII:R5H8897N95) LABETALOL HYDROCHLORIDE 5 mg in 1 mL Inactive Ingredients Ingredient Name Strength Water (UNII: 059QF0KO0R) Anhydrous Dextrose (UNII: 5SL0G7R0OK) 45 mg in 1 mL Edetate Disodium (UNII: 7FLD91C86K) 0.1 mg in 1 mL Methylparaben (UNII: A2I8C7HI9T) 0.8 mg in 1 mL Propylparaben (UNII: Z8IX2SC1OH) 0.1 mg in 1 mL Citric Acid Monohydrate (UNII: 2968PHW8QP) Sodium Hydroxide (UNII: 55X04QC32I) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:52533-034-20 4 mL in 1 SYRINGE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 02/23/2012 Labeler - Cantrell Drug Company (035545763)
